Results 191 to 200 of about 127,319 (303)

Infectious Diseases and Antimicrobial Resistance in the Gaza Strip: Epidemiological Drivers, Health System Disruptions, and Global Implications: A Narrative Review

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims The Gaza Strip has faced prolonged blockade, recurrent military conflicts, and systemic infrastructure collapse since October 2023, resulting in an unprecedented public health crisis characterized by surging infectious diseases and antimicrobial resistance (AMR).
Nima Farhadi, Aref Yarahmadi, Hamed Afkhami   +2 more
wiley   +1 more source

Harnessing conserved epitopes and multivalent antigen strategies for vaccine design: Lessons learned and opportunities. [PDF]

Hum Vaccin Immunother
Adjei-Gati E, Quaye CNO, Lamptey PO, Oklu LD, Kwofie JN, Hafiz YA, Kusi KA.   +6 more
europepmc   +1 more source

Geographic and Temporal Variations in Immunization Coverage in Nepal: An Ecological Time‐Trend Analysis

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Immunization remains a vital public health intervention in Nepal, yet significant disparities persist. This study evaluates the performance of Nepal's national immunization program by analyzing district‐level vaccination coverage and dropout rates from 2009 to 2022 to identify trends and disparities across different routine ...
Kritika Rana, Supreme Raj Pandey, Romila Chimoriya, Prakash Poudel, Bhupendra Man Singh Shrestha, Sandeep Kumar Okheda, Ritesh Chimoriya   +6 more
wiley   +1 more source

Evaluation of Maternal Immunization Rates in Primary Care: A Retrospective Study From Selected Family Health Centers in İstanbul, Türkiye. [PDF]

Int J Public Health
Aksu SB, Özmen Sever S, Gökseven Arda Y, Zeren Öztürk G.   +3 more
europepmc   +1 more source

Association Between Polymorphisms rs11003125 and rs7096206 of the MBL2 Gene and the Stages of Hepatitis B Progression in Burkina Faso: A Comparative Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Objectives Hepatitis B virus (HBV) infection remains a major global health burden, with disease progression influenced by host genetic and immune factors, including variants in the mannose‐binding lectin 2 (MBL2) gene. This study aimed to evaluate the association between MBL2 polymorphisms and clinical outcomes of HBV infection ...
Minane Nafissa Triande, Lassina Traore, Sidnooma Véronique Zongo, Teega‐Wendé Clarisse Ouedraogo, Mousso Savadogo, Sanata Nadine Kiemde, Tegwindé Rébéca Compaore, Augustin Tozoula Bambara, Roger Arsène Sombie, Patoinewendé Denise Ilboudo, Albert Théophane Yonli, Bolni Marius Nagalo, Florencia Wendkuuni Djigma, Jacques Simpore   +13 more
wiley   +1 more source

Hepatitis B vaccination at birth: science, myths, and the safety net imperative. [PDF]

Front Immunol
Gupta RK.
europepmc   +1 more source

Whispers of Pathogens; Social Contagion in Infectious Disease Dynamics: A Review

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Infectious disease dynamics are deeply intertwined with social structures, behaviors, and information systems. This narrative review examines how social factors conceptualized through the integrated lens of “social contagion” within a syndemic framework shape infectious disease patterns from January 2000 to January 2024 ...
Sayed Mortaza Fayez
wiley   +1 more source

Impact of Vaccines Across the Lifespan: A New Perspective in Public Health-Conclusions of an Expert Panel-Part 2. [PDF]

Vaccines (Basel)
Debbag R, Ávila-Agüero ML, Brea J, Espinal C, Romero-Feregrino R, Torres JR, Vázquez H, Cuadros R, Lazo-Páez G, Schilling A, Bonvehí P, Kairalla M, Rodríguez-Morales AJ.   +12 more
europepmc   +1 more source

Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Background The convergence of nanotechnology and immunotherapy has ushered in a transformative era in cancer treatment, offering new strategies to overcome pharmacokinetic limitations and immune evasion associated with conventional therapies. While immunotherapy, spanning checkpoint inhibitors, adoptive cell transfer, and cancer vaccines, has ...
Nima Javanmehr, Asal Moazzami Ashtyani, Robabehbeygom Ghafelehbashi, Fateme Mousavi, Hossein Teimouri   +4 more
wiley   +1 more source

Impact of Early COVID‐19 Antiviral Therapy on the Incidence of Uveitis: A Retrospective Cohort Study Using the TriNetX Database

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Objective To assess whether antivirals are associated with a reduced incidence of uveitis following COVID‐19. Methods We conducted a multi‐institutional, population‐based retrospective cohort study of adults (≥ 18 years) diagnosed with COVID‐19 between 2022 and 2024. Patients who received antiviral agents (Paxlovid, Molnupiravir, or Remdesivir)
Hou‐Ting Kuo, Alan Y. Hsu, De‐Yi Liu, Bing‐Qi Wu, James Cheng‐Chung Wei, Ning‐Yi Hsia, Yi‐Ching Shao, Chun‐Ting Lai, Chun‐Chi Chiang, Chun‐Ju Lin, Huan‐Sheng Chen, Yu‐Hsun Wang, Hsin Tseng, Ho‐Che Hsu, Yi‐Yu Tsai   +14 more
wiley   +1 more source